Journals / MN Oftalmoloji / 2022 / Cilt: 29 - Sayı: 1

Multimodal Imaging in Patients with Central Serous Chorioretinopathy

Santral Seröz Koryoretinopati Hastalarında Multimodal Görüntüleme

Pages
60–67
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The use of multimodal imaging methods can provide the physician with a better follow-up by providing comprehensive information about the diagnosis of the disease and its changes over time.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: This study aims to assess the multimodal imaging of macula and choroidal thickness with optical coherence tomography, fluorescein angiography and fundus autofluorescence in patients with central serous chorioretinopathy.
📊
Key Findings & Data:Material and Method: Eighty-eight eyes of 44 patients were included in the study.
💡
Conclusion & Impact:Conclusion: The use of multimodal imaging methods can provide the physician with a better follow-up by providing comprehensive information about the diagnosis of the disease and its changes over time.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: This study aims to assess the multimodal imaging of macula and choroidal thickness with optical coherence tomography, fluorescein angiography and fundus autofluorescence in patients with central serous chorioretinopathy. Material and Method: Eighty-eight eyes of 44 patients were included in the study. The patients were divided into 4 groups. Group I consists of eyes with inactive central serous chorioretinopathy, acute and chronic central serous chorioretinopathic eyes were included in Group II, Group III included the other healthy eyes of patients in Group I and Group II, and the eyes of healthy individuals without cent ral serous chorioretinopathic diagnosis in Group IV were included as control groups. Axial length, central macular thickness, subfoveal choroidal thickness, peripapillary choroidal thickness measurements and fluorescein angiography, fundus autofluorescence image features were examined. Results: Central macular thickness and subfoveal choroidal thickness values were found to be higher on all quadrants than in other groups in Group II. Mean subfoveal choroidal thickness values in eyes with inactive central serous chorioretinopathy were higher in all quadrants than the healthy control group. In all groups, there was a significant positive correlation between central macular thickness and subfoveal choroidal thickness values, and a significant negative correlation between axial length and subfoveal choroidal thickness values. In Group II, 16 ink-blot signs were observed in fluorescein angiography images in the affected eyes. In fundus autofluorescence imaging, granular pattern of hyperotofluorescence was observed in 12 eyes in Group I. Conclusion: The use of multimodal imaging methods can provide the physician with a better follow-up by providing comprehensive information about the diagnosis of the disease and its changes over time.

Özet

Amaç: Santral seröz koryoretinopati hastalarında maküla ve koroid kalınlığının optik koherans tomografi, floresein anjiyografi ve fundus otofloresans ile multimodal incelenmesi. Gereç ve Yöntem: Çalışmaya 44 hastanın 88 gözü alındı. Hastalar 4 gruba ayrıldı. Grup I’de inaktif santral seröz koryoretinopatili gözler (n=14), Grup II’ye akut ve kronik santral seröz koryoretinopatili gözler (n=30), Grup III’e Grup I ve Grup II’deki hastaların sağlam olan diğer gözleri (n=44), Grup IV’e santral seröz koryoretinopati tanısı olmayan sağlıklı bireylerin gözleri (n=32) kontrol grubu olarak dahil edildi. Aksiyel uzunluk, merkezi maküla kalınlığı, subfoveal koroid kalınlığı, peripapiller koroid kalınlığı ölçümleri ve hastaların floresein anjiyografi ve fundus otofloresans görüntü özellikleri incelendi. Bulgular: Grup II’de merkezi maküla kalınlığı ve subfoveal koroid kalınlığı değerlerinin tüm kadranlarda diğer gruplardan daha yüksek olduğu görüldü (p

🔖

Cite This Article

UÇAK, T., GÜVEN, D., DEMİR, M., ERGEN, E. (2022). Multimodal Imaging in Patients with Central Serous Chorioretinopathy. MN Oftalmoloji, Cilt: 29 - Sayı: 1, 60–67. https://ajindex.com/articles/581490

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Gass J. Pathogenesis of tears of the retinal pigment epithelium. Br J Ophthalmol 1984;68(8):513-9
  2. Hayashi K. Hasegawa Y. Tokoro T. Indocyanine green angiography of central serous chorioretinopathy. Int Ophthalmol. 1986; 9(1):37-41
  3. Bouzas EA. Karadimas P. Pournaras CJ. Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol. 2002;47(5): 431-48
  4. Turgut B. and Ergen İ. Santral Seröz Koryoretinopatinin Optik Koherens Tomografik Paternleri. Fırat Tıp Derg. 2013;18(1):39- 43
  5. Spaide RF. Koizumi H. Pozonni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146(4):496-500
  6. Imamura Y. Fujiwara T. Margolis R. Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina. 2009;29(10):1469-73
  7. Hall L. Guyer D. Yannuzzi L. Central serous chorioretinopathy. Ret-Vit. 1999;1:206-16
  8. Nicholson B. Noble J. Forooghian F. Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol. 2013;58(2):103-26
  9. Liew G. Quin G. Gillies M. Fraser-Bell S. Central serous chorioretinopathy: a review of epidemiology and pathophysiology. Clin Exper Ophthalmol. 2013;41(2):201-14
  10. Kitzman AS. Pulido JS. Diehl NN. Hodge DO. Burke JP. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology. 2008;115(1):169-73
  11. Spaide RF. Campeas L. Haas A. et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology. 1996;103(12):2070-80
  12. Haimovici R. Koh S. Gagnon DR. Lehrfeld T. Wellik S. Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology. 2004;111(2):244-9
  13. Gelişken Ö. Yılmaz S. Kaderli B. Kronik santral seröz koryoretinopati. Ret-Vit. 2007;15(1):1-6
  14. Ikuno Y. Kawaguchi K. Nouchi T. Yasuno Y. Choroidal thickness in healthy Japanese subjects. Invest Ophthalmol Vis Sci. 2010;51(4):2173-6
  15. Polat OA. Sinim N. Öner AÖ. Central choroidal and macular thickness in healthy Turkish subjects measured using spectral-domain optical coherence tomography. Ret-Vit. 2012;20(2):95-8
  16. Orduña-Azcona J. Pérez-Fernández E. Guadilla AM. De Manuel- Triantafilo S. Modamio L. Gili P. Sensitivity and specificity of choroidal thickness measurement by EDI-OCT for central serous chorioretinopathy diagnosis. Int Ophthalmol. 2021;41(1):257-64
  17. Yun C. Oh J. Han JY. Hwang SY. Moon SW. Huh K. Peripapillary choroidal thickne